Beverly C. Cordova

2.1k citations

34 papers · 1.8k indexed · h-index 20

Virology top 1%
- HIV Research and Treatment 19
Organic Chemistry top 2%
- Click Chemistry and Applications 7
- Synthesis and Biological Evaluation 4
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 29
- HIV/AIDS Research and Interventions 3
Pharmaceutical Science top 2%
Immunology top 10%
Molecular Biology
- Biochemical and Molecular Research 11
- Chemical Synthesis and Analysis 4
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 5

Co-authors: Ronald M. Klabe Susan Erickson‐Viitanen Lee T. Bacheler James D. Rodgers E. Knight George L. Trainor Mona Patel Robert J. McHugh
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)The Journal of Immunology (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

Beverly C. Cordova

34 papers receiving 1.7k citations

Peers

Countries citing papers authored by Beverly C. Cordova

Since Specialization

Citations

This map shows the geographic impact of Beverly C. Cordova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly C. Cordova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly C. Cordova more than expected).

Fields of papers citing papers by Beverly C. Cordova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly C. Cordova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly C. Cordova. The network helps show where Beverly C. Cordova may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Beverly C. Cordova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beverly C. Cordova Line = papers co-authored together Beverly C. Cordova links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors Bioorganic & Medicinal Chemistry Letters ·Robert F. Kaltenbach,Mona Patel,Robert E. Waltermire,Gregory D. Harris,Benjamin R. P. Stone,Ronald M. Klabe,Sena Garber,Lee T. Bacheler,Beverly C. Cordova,Kelly Logue,Matthew Wright,Susan Erickson‐Viitanen,George L. Trainor	2003	24
2	Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Chemistry & Biology ·Chien-An Chen,Scott McN. Sieburth,Athanasios Glekas,G. Hewitt,George L. Trainor,Susan Erickson‐Viitanen,Sena Garber,Beverly C. Cordova,Susan Jeffry,Ronald M. Klabe	2001	67
3	Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain Bioorganic & Medicinal Chemistry Letters ·Anthony J. Cocuzza,Dennis R. Chidester,Beverly C. Cordova,Susan Jeffrey,Rodney L. Parsons,Lee T. Bacheler,Susan Erickson‐Viitanen,George L. Trainor,Soo S. Ko	2001	67
4	Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of hIV-1 non-nucleoside reverse transcriptase Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,Kristen Jill Kresge,Senliang Pan,Beverly C. Cordova,Ronald M. Klabe,James D. Rodgers,Susan Erickson‐Viitanen	2001	13
5	Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,James D. Rodgers	2001	81
6	Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz Bioorganic & Medicinal Chemistry Letters ·Jay A. Markwalder,David D. Christ,Abdul Mutlib,Beverly C. Cordova,Ronald M. Klabe,Steven P. Seitz	2001	12
7	Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,Lisa A. Gearhart,Soo S. Ko,James D. Rodgers,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen	2000	13
8	Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,George L. Trainor,James D. Rodgers	2000	78
9	Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1′ substituents Bioorganic & Medicinal Chemistry Letters ·Robert F. Kaltenbach,Ronald M. Klabe,Beverly C. Cordova,Steven P. Seitz	1999	8
10	Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2′ substituents Bioorganic & Medicinal Chemistry Letters ·Mona Patel,James D. Rodgers,Robert J. McHugh,Barry L. Johnson,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,Soo S. Ko	1999	53
11	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,Barry L. Johnson,Haisheng Wang,Soo S. Ko,Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,Chong‐Hwan Chang,Susan Erickson‐Viitanen	1998	1
12	The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert F. Kaltenbach,David A. Nugiel,Robert J. McHugh,Prabhakar K. Jadhav,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Sena Garber,Carol Reid,Steven P. Seitz	1998	19
13	Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups Bioorganic & Medicinal Chemistry Letters ·James D. Rodgers,Barry L. Johnson,Wang Hai-sheng,Susan Erickson‐Viitanen,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Chong‐Hwan Chang	1998	34
14	The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Lee T. Bacheler,Marlene M. Rayner,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Steven P. Seitz	1998	16
15	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,Barry L. Johnson,Haisheng Wang,Soo S. Ko,Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,Chang-Hwan Chang,Susan Erickson‐Viitanen	1998	32
16	Population Dynamics Studies of Wild-Type and Drug-Resistant Mutant HIV in Mixed Infections Virology ·Marlene M. Rayner,Beverly C. Cordova,David A. Jackson	1997	20
17	Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors Journal of Medicinal Chemistry ·George V. De Lucca,Jing Liang,Paul E. Aldrich,J. C. CALABRESE,Beverly C. Cordova,Ronald M. Klabe,Marlene M. Rayner,Chong‐Hwan Chang	1997	40
18	A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl)-cyclic urea as a HIV protease inhibitor Bioorganic & Medicinal Chemistry Letters ·W. W. WILKERSON,Andrea Hollis,Walter W. Cheatham,Gilbert N. Lam,Susan Erickson‐Viitanen,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,James L. Meek	1995	5
19	DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein Antimicrobial Agents and Chemotherapy ·Marlene M. Rayner,Beverly C. Cordova,R P Meade,Paul E. Aldrich,P. K. JADHAV,Y. Ru,Patrick Y. S. Lam	1994	15
20	A 15-kD Interferon-Induced Protein and Its 17-kD Precursor: Expression in Escherichia coli , Purification, and Characterization Journal of Interferon Research ·NEIL FELTHAM,Milton C. Hillman,Beverly C. Cordova,DIANA FAHEY,BARBARA LARSEN,Dale C. Blomstrom,Ernest Knight	1989	8

About Beverly C. Cordova

Beverly C. Cordova is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (19 papers), Biochemical and Molecular Research (11 papers), Click Chemistry and Applications (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Chemical Synthesis and Analysis (4 papers), Synthesis and Biological Evaluation (4 papers) and HIV/AIDS Research and Interventions (3 papers). The work is most often cited by research in Virology (499 citations), Organic Chemistry (889 citations) and Infectious Diseases (557 citations). Beverly C. Cordova has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ronald M. Klabe, Susan Erickson‐Viitanen, Lee T. Bacheler, James D. Rodgers, E. Knight, George L. Trainor, Mona Patel, Robert J. McHugh, Susan Jeffrey and Soo S. Ko. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact